Search Within

Michael Andrew Postow

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (32)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (81)
  2. Melanoma Disease Management Team (81)
  3. Melanoma and Immunotherapeutics Service (81)
  4. Population Sciences Research Program (81)
  5. Solid Tumor Oncology Division (81)
  6. Epidemiology and Biostatistics (69)

More Groups

People
  1. Katherine Panageas (64)
  2. Jedd Wolchok (48)
  3. Alexander Shoushtari (34)
  4. Margaret Callahan (34)
  5. Paul Chapman (32)
  6. Parisa Momtaz (26)

More People

Years
  1. 2025 (5)
  2. 2024 (8)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. The Oncologist (7)
  3. Annals of Surgical Oncology (5)
  4. Journal for ImmunoTherapy of Cancer (5)
  5. Clinical Cancer Research (4)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Oxford University Press (8)
  3. American Association for Cancer Research (7)
  4. Biomed Central Ltd (5)
  5. Springer (5)
  6. Wiley Blackwell (5)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Management and outcomes of clostridioides difficile infection in patients on immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Satish, D.; Kamboj, M.; Babady, N. E.; Baul, J.; Kalvin, H. L.; Panageas, K.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma
    Journal Article

    Smithy, J. W.; Peng, X.; Ehrich, F. D.; Moy, A. P.; Yosofvand, M.; Maher, C.; Aleynick, N.; Vanguri, R.; Zhuang, M.; Lee, J.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment
    Journal Article

    Mao, J. J.; Bryl, K.; Gillespie, E. F.; Green, A.; Hung, T. K. W.; Baser, R.; Panageas, K.; Postow, M. A.; Daly, B.
    npj Digital Medicine (2025)

    Fulltext@MSK | Save
  • First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment
    Meeting Abstract

    Postow, M. A.; Burgos, G.; DeCongelio, M.; Palaia, J.; Ejzykowicz, F.; Patel, D.; Rosenblatt, L.; Modi, K.; Pittman, Z.; Honomichl, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Warner, A. B.; Smithy, J. W.; Postow, M. A.; Panageas, K.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save